Lee Sung's Form 4 filing
Cytokinetics Inc (CYTK) · filed Jun 29, 2026
- Accession no.
- 0001061983-26-000070
- Filed
- Jun 29, 2026
- Trade date
- Jun 29, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 5 derivative transactions. Open-market sales total $266.4K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lee SungCIK 0001793200 | Officer (EVP, Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Common Stock | MOption exerciseAcquired | +188 | $44.36 | +$8,339.68 | 63,409 | Direct | |
| Jun 29, 2026 | Common Stock | MOption exerciseAcquired | +822 | $44.36 | +$36,463.92 | 64,231 | Direct | |
| Jun 29, 2026 | Common Stock | MOption exerciseAcquired | +1,113 | $48.51 | +$53,991.63 | 65,344 | Direct | |
| Jun 29, 2026 | Common Stock | MOption exerciseAcquired | +188 | $44.36 | +$8,339.68 | 65,532 | Direct | |
| Jun 29, 2026 | Common Stock | MOption exerciseAcquired | +823 | $44.36 | +$36,508.28 | 66,355 | Direct | |
| Jun 29, 2026 | Common Stock | SSaleDisposed | −3,134 | $85.00 | −$266,390 | 63,221 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Common Stock | MOption exerciseDisposed | −188 | $0.00 | $0 | 8,828 | Direct | |
| Jun 29, 2026 | Common Stock | MOption exerciseDisposed | −822 | $0.00 | $0 | 40,504 | Direct | |
| Jun 29, 2026 | Common Stock | MOption exerciseDisposed | −1,113 | $0.00 | $0 | 52,304 | Direct | |
| Jun 29, 2026 | Common Stock | MOption exerciseDisposed | −188 | $0.00 | $0 | 8,640 | Direct | |
| Jun 29, 2026 | Common Stock | MOption exerciseDisposed | −823 | $0.00 | $0 | 39,681 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.